ENGIE Resources, a subsidiary of ENGIE North America, has announced a nine-year renewable energy supply agreement with AstraZeneca to provide solar power and Renewable Energy Credits (RECs) through 2034. The clean energy will support AstraZeneca’s manufacturing site in Coppell, Texas, helping advance the company’s global sustainability goals.
The agreement will source power from the Tyson Nick Solar Project, a 114 MW solar facility located in Lamar County, Texas, approximately 90 miles northeast of Dallas. The initiative is expected to prevent 94,447 metric tons of CO₂ emissions—equivalent to avoiding the combustion of 105 million pounds of coal.
This partnership reflects AstraZeneca’s continued commitment to environmental stewardship and aligns with ENGIE’s mission to accelerate the energy transition through innovative, customer-focused renewable solutions.
“This joint effort with AstraZeneca exemplifies how leading organizations can align climate ambition with meaningful action,” said Anne-Laure Chassanite, CEO of ENGIE Resources. “We’re proud to deliver renewable energy in support of AstraZeneca’s decarbonization goals—and deeply grateful to the dedicated teams across both organizations whose expertise and collaboration made this agreement possible.”
“By securing renewable energy for our Texas operations, AstraZeneca is proud to lead by example in reducing emissions and building a resilient supply chain,” said Jim Fox, Senior Vice President, Americas Supply Operations at AstraZeneca. “This partnership illustrates how innovative thinking, shared values, and action can accelerate the transition to cleaner energy, benefitting both our business and our communities.”
Subscribe to get the latest posts sent to your email.
